Innovating Works

Armada Technologies Limited

A stranger
VISION DMD: VISION DMD Phase 2 Clinical Trials of VBP15 An Innovative Steroid like Intervention on Duchenne M... Armada Technologies Limited participó en un H2020: H2020-PHC-2014-2015 VISION-DMD aims to advance clinical development of the orphan drug VBP15 as a new therapy to revolutionise care for all patients with Duchen...
2015-12-09 - 2021-12-31 | financed
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.